Healthcare Sector Update-November 2015

Healthcare stock prices have been pressured by election policy discussions and many believe share prices may continue to be impacted. Over the last three months (ending October 30, 2015), the overall S&P declined 1.4% while the S&P 500-Pharmaceuticals, Biotechnology and Life Sciences Index declined 6.1%, despite the defensive nature of the sector.

Healthcare Sector Update-November 2015 2015-11-30T00:00:00.0000000 /insights/publications/m-and-a/healthcare-sector-update---november-2015 publication {D59CA77E-C551-45A3-BE89-F567210C5A60} {4DACD310-421A-42AC-BEF4-8AA7E70484CD} {13E28841-C245-441D-8C3B-49E72DA5381C} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {DF0A8D82-EB98-4261-8951-BF842E034FA8}

Related Services

Duff & Phelps Corporate Finance

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance
Duff & Phelps Corporate Finance

Corporate Finance

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior deal execution.

M&A Advisory
Duff & Phelps Corporate Finance

Corporate Finance

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group
Duff & Phelps Corporate Finance

Corporate Finance

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services
Duff & Phelps Corporate Finance

Corporate Finance

Private Capital Markets

Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.

Private Capital Markets

Case Studies

Insights